Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Current Opinion in Endocrinology, Diabetes, and Obesity|July 16, 2021
Survival benefit of endocrine dysfunction following immune checkpoint inhibitors for nonthyroidal cancersAnupam Kotwal, Mabel Ryder
Nature Reviews. Clinical Oncology|March 2, 2016
Evolving molecularly targeted therapies for advanced-stage thyroid cancersKeith C Bible, Mabel Ryder
Thyroid : Official Journal of the American Thyroid Association|December 10, 2019
PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer PatientsAnupam Kotwal, Lisa Kottschade, Mabel Ryder
Endocrine Reviews|July 20, 2019
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and BeyondMaria E Cabanillas, Mabel Ryder, Camilo Jimenez
Journal for Immunotherapy of Cancer|July 2, 2014
Strategies for improving the reporting of human immunophenotypes by flow cytometryMichael P Gustafson, Yi Lin, Mabel Ryder, et al.
Endocrine-Related Cancer|March 11, 2014
Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institutionMabel Ryder, Margaret Callahan, Michael A Postow, et al.
Thyroid : Official Journal of the American Thyroid Association|October 21, 2016
Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid NodulesMichele M Merten, M Regina Castro, Jun Zhang, et al.
The Lancet. Diabetes & Endocrinology|October 25, 2016
Leveraging the immune system to treat advanced thyroid cancersJena D French, Keith Bible, Christine Spitzweg, et al.
Frontiers in Immunology|January 18, 2024
Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancerAnupam Kotwal, Michael P Gustafson, Svetlana Bornschlegl, et al.
Clinical Nuclear Medicine|December 22, 2020
123I Scan With Whole-Body Retention Measurement at 48 Hours for Simplified Dosimetry Before 131I Treatment of Metastatic Thyroid CancerJolanta M Durski, Carrie B Hruska, Trond V Bogsrud, et al.
Pageof 6